Skip to main content

CORRECTION article

Front. Immunol., 26 January 2024
Sec. Microbial Immunology
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1365827

Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

This article is a correction to:

  1. Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?

    1. Read original article
Jos M. Prez de la Lastra*&#x;José M. Pérez de la Lastra1*†Uttpal Anand*&#x;Uttpal Anand2*†Sergio Gonzlez-AcostaSergio González-Acosta1Manuel R. LpezManuel R. López1Abhijit DeyAbhijit Dey3Elza BontempiElza Bontempi4Antonio Morales delaNuezAntonio Morales delaNuez1
  • 1Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain
  • 2CytoGene Research & Development LLP, Barabanki, Uttar Pradesh, India
  • 3Department of Life Sciences, Presidency University, Kolkata, India
  • 4National Interuniversity Consortium of Materials Science and Technology (INSTM) and Chemistry for Technologies Laboratory, Department of Mechanical and Industrial Engineering, University of Brescia, Brescia, Italy

A Corrigendum on
Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

By Pérez de la Lastra JM, Anand U, González-Acosta S, López MR, Dey A, Bontempi E and Morales delaNuez A (2022). Front. Immunol. 13:921483. doi: 10.3389/fimmu.2022.921483

In the published article, there was an error in the affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel”, it should be “CytoGene Research & Development LLP, Uttar Pradesh, India”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, antibiotic resistance, one health approach, global health, antibiotic discovery, antimicrobial peptides, environmental contamination, vaccination

Citation: Pérez de la Lastra JM, Anand U, González-Acosta S, López MR, Dey A, Bontempi E and delaNuez AM (2024) Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides? Front. Immunol. 15:1365827. doi: 10.3389/fimmu.2024.1365827

Received: 05 January 2024; Accepted: 08 January 2024;
Published: 26 January 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Pérez de la Lastra, Anand, González-Acosta, López, Dey, Bontempi and delaNuez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: José M. Pérez de la Lastra, jm.perezdelalastra@csic.es; Uttpal Anand, ushuats@gmail.com

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.